Keating Investment Counselors Inc Johnson & Johnson Transaction History

Keating Investment Counselors Inc

  • $244 Million
  • Q3 2024

A detailed history of Keating Investment Counselors Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Keating Investment Counselors Inc holds 15,194 shares of JNJ stock, worth $2.22 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares
15,194
Previous 16,099 5.62%
Holding current value
$2.22 Million
Previous $2.35 Million 4.63%
% of portfolio
1.01%
Previous 1.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$145.48 - $167.38 $131,659 - $151,478
-905 Reduced 5.62%
15,194 $2.46 Million
Q2 2024

Aug 06, 2024
SELL
$144.38 - $157.78 $56,596 - $61,849
-392 Reduced 2.38%
16,099 $2.35 Million
Q1 2024

May 07, 2024
SELL
$155.22 - $162.74 $1.08 Million - $1.13 Million
-6,934 Reduced 29.6%
16,491 $2.61 Million
Q4 2023

Feb 07, 2024
SELL
$145.6 - $158.88 $78,478 - $85,636
-539 Reduced 2.25%
23,425 $3.67 Million
Q3 2023

Oct 25, 2023
SELL
$155.75 - $174.48 $140,953 - $157,904
-905 Reduced 3.64%
23,964 $3.73 Million
Q2 2023

Aug 02, 2023
SELL
$154.35 - $166.11 $267,025 - $287,370
-1,730 Reduced 6.5%
24,869 $4.12 Million
Q1 2023

May 04, 2023
SELL
$151.05 - $180.26 $262,071 - $312,751
-1,735 Reduced 6.12%
26,599 $4.12 Million
Q4 2022

Feb 08, 2023
BUY
$160.2 - $179.79 $942,937 - $1.06 Million
5,886 Added 26.22%
28,334 $5.01 Million
Q3 2022

Nov 03, 2022
SELL
$161.33 - $179.52 $876,828 - $975,691
-5,435 Reduced 19.49%
22,448 $3.67 Million
Q2 2022

Aug 03, 2022
SELL
$168.19 - $186.01 $507,933 - $561,750
-3,020 Reduced 9.77%
27,883 $4.95 Million
Q1 2022

Apr 28, 2022
SELL
$158.14 - $179.59 $128,251 - $145,647
-811 Reduced 2.56%
30,903 $5.48 Million
Q4 2021

Jan 26, 2022
SELL
$155.93 - $173.01 $79,056 - $87,716
-507 Reduced 1.57%
31,714 $5.43 Million
Q3 2021

Oct 27, 2021
SELL
$161.5 - $179.47 $58,140 - $64,609
-360 Reduced 1.1%
32,221 $5.2 Million
Q2 2021

Jul 29, 2021
SELL
$159.48 - $171.07 $325,339 - $348,982
-2,040 Reduced 5.89%
32,581 $5.37 Million
Q1 2021

Apr 26, 2021
SELL
$153.07 - $170.48 $264,811 - $294,930
-1,730 Reduced 4.76%
34,621 $5.69 Million
Q4 2020

Jan 27, 2021
SELL
$137.11 - $157.38 $27,422 - $31,476
-200 Reduced 0.55%
36,351 $5.72 Million
Q3 2020

Oct 23, 2020
SELL
$140.38 - $153.83 $126,342 - $138,447
-900 Reduced 2.4%
36,551 $5.44 Million
Q2 2020

Jul 22, 2020
SELL
$128.81 - $155.51 $219,621 - $265,144
-1,705 Reduced 4.35%
37,451 $5.27 Million
Q1 2020

Apr 29, 2020
SELL
$111.14 - $153.99 $302,078 - $418,544
-2,718 Reduced 6.49%
39,156 $5.14 Million
Q4 2019

Jan 28, 2020
SELL
$127.5 - $146.44 $117,937 - $135,457
-925 Reduced 2.16%
41,874 $6.11 Million
Q3 2019

Oct 28, 2019
SELL
$126.95 - $142.14 $342,130 - $383,067
-2,695 Reduced 5.92%
42,799 $5.54 Million
Q2 2019

Aug 01, 2019
SELL
$131.15 - $144.24 $1.65 Million - $1.81 Million
-12,568 Reduced 21.65%
45,494 $6.34 Million
Q1 2019

Apr 22, 2019
SELL
$125.72 - $139.79 $184,808 - $205,491
-1,470 Reduced 2.47%
58,062 $8.12 Million
Q4 2018

Feb 12, 2019
SELL
$122.84 - $147.84 $171,607 - $206,532
-1,397 Reduced 2.29%
59,532 $7.68 Million
Q3 2018

Oct 30, 2018
SELL
$121.58 - $142.88 $826,257 - $971,012
-6,796 Reduced 10.03%
60,929 $8.42 Million
Q2 2018

Aug 01, 2018
SELL
$119.4 - $131.76 $102,684 - $113,313
-860 Reduced 1.25%
67,725 $8.22 Million
Q1 2018

May 11, 2018
SELL
$125.1 - $148.14 $414,206 - $490,491
-3,311 Reduced 4.61%
68,585 $8.79 Million
Q4 2017

Feb 14, 2018
SELL
$131.22 - $143.62 $105,632 - $115,614
-805 Reduced 1.11%
71,896 $10 Million
Q3 2017

Nov 09, 2017
SELL
$129.47 - $135.38 $84,155 - $87,997
-650 Reduced 0.89%
72,701 $9.45 Million
Q2 2017

Aug 10, 2017
BUY
N/A
73,351
73,351 $9.7 Million

Others Institutions Holding JNJ

# of Institutions
4,275
Shares Held
1.68B
Call Options Held
17.6M
Put Options Held
14.5M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Keating Investment Counselors Inc Portfolio

Follow Keating Investment Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keating Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Keating Investment Counselors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email